Schoemaker RG - Search Results

1

A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.

Lipsic E, van der Meer P, Voors AA, Westenbrink BD, van den Heuvel AF, de Boer HC, van Zonneveld AJ, Schoemaker RG, van Gilst WH, Zijlstra F, van Veldhuisen DJ. Lipsic E, et al. Among authors: schoemaker rg. Cardiovasc Drugs Ther. 2006 Apr;20(2):135-41. doi: 10.1007/s10557-006-7680-5. Cardiovasc Drugs Ther. 2006. PMID: 16761193 Clinical Trial.

2

Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.

Westendorp B, Schoemaker RG, Buikema H, de Zeeuw D, van Veldhuisen DJ, van Gilst WH. Westendorp B, et al. Among authors: schoemaker rg. J Renin Angiotensin Aldosterone Syst. 2004 Mar;5(1):27-32. doi: 10.3317/jraas.2004.004. J Renin Angiotensin Aldosterone Syst. 2004. PMID: 15136971 Free article.

3

Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.

Lipsic E, van der Meer P, Henning RH, Suurmeijer AJ, Boddeus KM, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Lipsic E, et al. Among authors: schoemaker rg. J Cardiovasc Pharmacol. 2004 Oct;44(4):473-9. doi: 10.1097/01.fjc.0000140209.04675.c3. J Cardiovasc Pharmacol. 2004. PMID: 15454856

4

Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.

van der Meer P, Lipsic E, Henning RH, Boddeus K, van der Velden J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. van der Meer P, et al. Among authors: schoemaker rg. J Am Coll Cardiol. 2005 Jul 5;46(1):125-33. doi: 10.1016/j.jacc.2005.03.044. J Am Coll Cardiol. 2005. PMID: 15992646 Free article.

5

Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction.

Westendorp B, Schoemaker RG, Buikema H, Boomsma F, van Veldhuisen DJ, van Gilst WH. Westendorp B, et al. Among authors: schoemaker rg. Eur J Heart Fail. 2006 Mar;8(2):122-30. doi: 10.1016/j.ejheart.2005.04.014. Epub 2005 Aug 5. Eur J Heart Fail. 2006. PMID: 16084760 Free article.

6

Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.

van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH. van der Meer P, et al. Among authors: schoemaker rg. Circulation. 2005 Sep 20;112(12):1743-7. doi: 10.1161/CIRCULATIONAHA.105.549121. Circulation. 2005. PMID: 16172283

7

Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction.

Westendorp B, Schoemaker RG, van Gilst WH, Buikema H. Westendorp B, et al. Among authors: schoemaker rg. J Cardiovasc Pharmacol. 2005 Dec;46(6):766-72. doi: 10.1097/01.fjc.0000187175.05780.e2. J Cardiovasc Pharmacol. 2005. PMID: 16306800

8

Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.

Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H. Westendorp B, et al. Among authors: schoemaker rg. Eur J Pharmacol. 2005 Dec 19;527(1-3):141-9. doi: 10.1016/j.ejphar.2005.10.019. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16310764

9

Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.

Westendorp B, Schoemaker RG, Buikema H, de Zeeuw D, Boomsma F, van Gilst WH, van Veldhuisen DJ. Westendorp B, et al. Among authors: schoemaker rg. Eur J Heart Fail. 2005 Dec;7(7):1085-94. doi: 10.1016/j.ejheart.2004.12.002. Eur J Heart Fail. 2005. PMID: 16326361 Free article.

10

Treprostinil in advanced experimental pulmonary hypertension: beneficial outcome without reversed pulmonary vascular remodeling.

van Albada ME, van Veghel R, Cromme-Dijkhuis AH, Schoemaker RG, Berger RM. van Albada ME, et al. Among authors: schoemaker rg. J Cardiovasc Pharmacol. 2006 Nov;48(5):249-54. doi: 10.1097/01.fjc.0000248229.87510.9b. J Cardiovasc Pharmacol. 2006. PMID: 17110807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page